theophylline has been researched along with Colorectal Cancer in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
" CYP2A6 phenotype was determined using caffeine as a probe drug in individuals participating in a case-control study of colorectal cancer (127 cases and 333 controls matched on age, gender, race, and geographic region)." | 7.71 | CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. ( Hammons, G; Kadlubar, FF; Lang, NP; Nowell, S; Sweeney, C, 2002) |
" CYP2A6 phenotype was determined using caffeine as a probe drug in individuals participating in a case-control study of colorectal cancer (127 cases and 333 controls matched on age, gender, race, and geographic region)." | 3.71 | CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. ( Hammons, G; Kadlubar, FF; Lang, NP; Nowell, S; Sweeney, C, 2002) |
"The pathogenesis for colorectal cancer remains unresolved." | 1.36 | Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia. ( Bindslev, N; Hansen, MB; Kaltoft, N; Osbak, PS; Poulsen, SS; Tilotta, MC; Witte, AB, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaltoft, N | 1 |
Tilotta, MC | 1 |
Witte, AB | 1 |
Osbak, PS | 1 |
Poulsen, SS | 1 |
Bindslev, N | 1 |
Hansen, MB | 1 |
Nowell, S | 1 |
Sweeney, C | 1 |
Hammons, G | 1 |
Kadlubar, FF | 1 |
Lang, NP | 1 |
2 other studies available for theophylline and Colorectal Cancer
Article | Year |
---|---|
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Topics: Alprostadil; Biopsy; Bumetanide; Colforsin; Colon; Colorectal Neoplasms; Dinoprostone; Female; Human | 2010 |
CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Biomarkers; Caffeine; Case-Control Studies; Central Nerv | 2002 |